On February 9, 2026, Waters Corporation completed the spin-off of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business, merging it with Waters, resulting in a combined entity where former BD shareholders own approximately 39.2% of Waters' shares. Waters also issued 38,541,851 shares to these former BD shareholders as part of the merger process.